4.7 Article

The ubiquitin-specific protease 8 antagonizes melatonin-induced endocytic degradation of MT1 receptor to promote lung adenocarcinoma growth

Related references

Note: Only part of the references are listed.
Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biochemistry & Molecular Biology

The oncogenic role of ubiquitin specific peptidase (USP8) and its signaling pathways targeting for cancer therapeutics

Md. Tariqul Islam et al.

Summary: USP8, as a deubiquitinating enzyme, plays a crucial role in stabilizing oncogenes and proto-oncogenes by activating multiple signaling pathways that promote cancer progression. Inhibiting USP8 could potentially overcome drug resistance in cancer treatment.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Article Biochemistry & Molecular Biology

USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis

Shuyan Liu et al.

Summary: Liquid-liquid phase separation is a generic approach to studying the dynamic regulation of phase-separated assemblies and the roles of protein posttranslational modifications. USP42, a deubiquitylase, has been identified to play a pivotal role in nuclear speckle phase separation, mRNA splicing, and cancer cell growth. Inhibition of USP42 presents a novel anticancer strategy by targeting phase separation.

CELL DEATH AND DIFFERENTIATION (2021)

Review Oncology

Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake

Alessandro De Toma et al.

Summary: Targeted therapies have revolutionized the treatment of non-small cell lung cancer, with new data on less common alterations such as ROS1, BRAF, RET, HER2, NTRK, MET emerging beyond EGFR and ALK mutations. Research is ongoing to explore the characteristics of patients with these alterations and potential resistance mechanisms to therapies.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Article Biochemistry & Molecular Biology

Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met

Mohamed Y. Zaky et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)

Review Oncology

RNA sequencing: new technologies and applications in cancer research

Mingye Hong et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Ubiquitin-specific protease 8 (USP8/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions

Almut Dufner et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2019)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Review Oncology

Melatonin for the prevention and treatment of cancer

Ya Li et al.

ONCOTARGET (2017)

Review Biochemistry & Molecular Biology

Deubiquitylating enzymes in receptor endocytosis and trafficking

Aidan P. McCann et al.

BIOCHEMICAL JOURNAL (2016)

Article Cell Biology

A functional endosomal pathway is necessary for lysosome biogenesis in Drosophila

Anne-Claire Jacomin et al.

BMC CELL BIOLOGY (2016)

Article Clinical Neurology

Melatonin: Physiological effects in humans

B. Claustrat et al.

NEUROCHIRURGIE (2015)

Review Pharmacology & Pharmacy

Deubiquitinase inhibition as a cancer therapeutic strategy

Padraig D'Arcy et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Review Biochemistry & Molecular Biology

Melatonin: Buffering the Immune System

Antonio Carrillo-Vico et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Review Physiology

DEUBIQUITYLASES FROM GENES TO ORGANISM

Michael J. Clague et al.

PHYSIOLOGICAL REVIEWS (2013)

Article Cell Biology

Endocytosis of Receptor Tyrosine Kinases

Lai Kuan Goh et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)

Review Cell Biology

Governance of Endocytic Trafficking and Signaling by Reversible Ubiquitylation

Michael J. Clague et al.

DEVELOPMENTAL CELL (2012)

Article Cell Biology

Cellular functions of the DUBs

Michael J. Clague et al.

JOURNAL OF CELL SCIENCE (2012)

Review Physiology

ENDOCYTOSIS AND SIGNALING: CELL LOGISTICS SHAPE THE EUKARYOTIC CELL PLAN

Sara Sigismund et al.

PHYSIOLOGICAL REVIEWS (2012)

Article Multidisciplinary Sciences

Global quantification of mammalian gene expression control

Bjoern Schwanhaeusser et al.

NATURE (2011)

Article Biochemistry & Molecular Biology

The therapeutic potential of deubiquitinating enzyme inhibitors

Frederic Colland

BIOCHEMICAL SOCIETY TRANSACTIONS (2010)

Review Cell Biology

Breaking the chains: structure and function of the deubiquitinases

David Komander et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)

Review Oncology

Therapeutic actions of melatonin in cancer: Possible mechanisms

Venkataramanujan Srinivasan et al.

INTEGRATIVE CANCER THERAPIES (2008)

Article Endocrinology & Metabolism

C-terminal domains within human MT1 and MT2 melatonin receptors are involved in internalization processes

Shalini Sethi et al.

JOURNAL OF PINEAL RESEARCH (2008)

Review Oncology

Derailed endocytosis: an emerging feature of cancer

Yaron Mosesson et al.

NATURE REVIEWS CANCER (2008)

Review Cell Biology

Endocytosis:: the DUB version

Michael J. Clague et al.

TRENDS IN CELL BIOLOGY (2006)

Review Pharmacology & Pharmacy

Molecular tools to study melatonin pathways and actions

JA Boutin et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2005)

Article Cell Biology

AMSH is an endosome-associated ubiquitin isopeptidase

J McCullough et al.

JOURNAL OF CELL BIOLOGY (2004)